These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 6684713)

  • 1. Differential antiestrogen action in the immature rat uterus: a comparison of hydroxylated antiestrogens with high affinity for the estrogen receptor.
    Jordan VC; Gosden B
    J Steroid Biochem; 1983 Sep; 19(3):1249-58. PubMed ID: 6684713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the uterotropic activity of estrogens and antiestrogens by the short acting antiestrogen LY117018.
    Jordan VC; Gosden B
    Endocrinology; 1983 Aug; 113(2):463-8. PubMed ID: 6872937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for biological action of the antiestrogens LY117018 and tamoxifen by different mechanisms.
    Black LJ; Goode RL
    Endocrinology; 1981 Sep; 109(3):987-9. PubMed ID: 7262030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular effects of antiestrogens (tamoxifen and LY117018) on estrogen-dependent glycoprotein (USP-1) synthesized and secreted by rat uterine epithelial cells.
    Takeda A; Shimizu S
    Endocrinology; 1988 Jul; 123(1):258-63. PubMed ID: 3383775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposing biological actions of antiestrogens in vitro and in vivo: induction of progesterone receptor in the rat and mouse uterus.
    Campen CA; Jordan VC; Gorski J
    Endocrinology; 1985 Jun; 116(6):2327-36. PubMed ID: 3996316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of rat uterine steroid hormone receptors by estrogen and antiestrogen.
    Dix CJ; Jordan VC
    Endocrinology; 1980 Dec; 107(6):2011-20. PubMed ID: 7191796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The stimulation of uterine complement component C3 gene expression by antiestrogens.
    Sundstrom SA; Komm BS; Xu Q; Boundy V; Lyttle CR
    Endocrinology; 1990 Mar; 126(3):1449-56. PubMed ID: 2307112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonism of estrogen- and antiestrogen-induced uterine complement component C3 expression by ICI 164,384.
    Galman MS; Sundstrom SA; Lyttle CR
    J Steroid Biochem; 1990 Jul; 36(4):281-6. PubMed ID: 2391957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding characteristics of novel nonsteroidal antiestrogens to the rat uterine estrogen receptors.
    Martel C; Provencher L; Li X; St Pierre A; Leblanc G; Gauthier S; Mérand Y; Labrie F
    J Steroid Biochem Mol Biol; 1998 Feb; 64(3-4):199-205. PubMed ID: 9605415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-related effects of a triphenylethylene antiestrogen on estrogen-induced changes in uterine weight, estrogen receptors, and endometrial sensitivity in rats.
    Trivedi RN; Chauhan SC; Dwivedi A; Kamboj VP; Singh MM
    Contraception; 1995 Jun; 51(6):367-79. PubMed ID: 7554978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential sensitivity of rat uterine growth and epithelium hypertrophy to estrogens and antiestrogens.
    Branham WS; Zehr DR; Sheehan DM
    Proc Soc Exp Biol Med; 1993 Jul; 203(3):297-303. PubMed ID: 8516342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antiestrogen LY117018 is estrogenic in the fetal rat.
    Henry EC; Miller RK
    Teratology; 1986 Aug; 34(1):59-63. PubMed ID: 3764778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the biological effects of tamoxifen and a new antioestrogen (LY 117018) on the immature rat uterus.
    Wakeling AE; O'Connor KM; Newboult E
    J Endocrinol; 1983 Dec; 99(3):447-53. PubMed ID: 6644235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen- and antiestrogen-induced ornithine decarboxylase activity and uterine growth in the rat.
    Branham WS; Leamons ML; Sheehan DM
    J Steroid Biochem; 1988 Feb; 29(2):153-9. PubMed ID: 3347055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of rat uterine progesterone receptor levels and peroxidase activity by tamoxifen citrate, LY117018, and estradiol.
    Keeping HS; Lyttle CR
    Endocrinology; 1982 Dec; 111(6):2046-54. PubMed ID: 6890442
    [No Abstract]   [Full Text] [Related]  

  • 16. In vivo and in vitro antiestrogenic action of 3-hydroxytamoxifen, tamoxifen and 4-hydroxytamoxifen.
    Löser R; Seibel K; Roos W; Eppenberger U
    Eur J Cancer Clin Oncol; 1985 Aug; 21(8):985-90. PubMed ID: 4043181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The binding of [3H]-oestradiol-17 beta in the immature rat uterus during the sequential administration of non-steroidal anti-oestrogens.
    Jordan VC; Naylor KE
    Br J Pharmacol; 1979 Feb; 65(2):167-73. PubMed ID: 760895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential interaction of antiestrogens with cytosol estrogen receptors.
    Black LJ; Jones CD; Goode RL
    Mol Cell Endocrinol; 1981 Apr; 22(1):95-103. PubMed ID: 7239000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of the alkylaminoethoxy side-chain for the estrogenic and antiestrogenic actions of tamoxifen and trioxifene in the immature rat uterus.
    Jordan VC; Gosden B
    Mol Cell Endocrinol; 1982 Aug; 27(3):291-306. PubMed ID: 7128917
    [No Abstract]   [Full Text] [Related]  

  • 20. Androgen-uterine interactions: an assessment of androgen interaction with the testosterone- and estrogen-receptor systems and stimulation of uterine growth and progesterone-receptor synthesis.
    Schmidt WN; Katzenellenbogen BS
    Mol Cell Endocrinol; 1979 Aug; 15(2):91-108. PubMed ID: 499651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.